Evidence map›Paper›PMID 30943398›Full record

ArticleCell reports2019

Transcriptional Circuit Fragility Influences HIV Proviral Fate.

Emily L Morton, Christian V Forst, Yue Zheng, Ana B DePaula-Silva, Nora-Guadalupe P Ramirez, Vicente Planelles, Iván D'Orso

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. KAP1 in antiviral immunity: dual roles in viral silencing and immune regulation.Frontiers in cellular and infection microbiology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Cure and Long-Term Remission Strategies.Methods in molecular biology (Clifton, N.J.) · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Emily L MortonDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Christian V ForstDepartment of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Yue ZhengDivision of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Ana B DePaula-SilvaDivision of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Nora-Guadalupe P RamirezDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Vicente PlanellesDivision of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Iván D'OrsoDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: ivan.dorso@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · USUniversity of Utah · USIcahn School of Medicine at Mount Sinai · US

Funding

Omics-Based Predictive Modeling of Age-Dependent Outcome to Influenza InfectionU01AI111598 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GHEDIN, ELODIE · 2013 to 2017
$13.3M
MECHANISMS OF DRUG ACTION AND DISPOSITIONT32GM007062 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI MANGELSDORF, DAVID J · 1985 to 2020
$7.4M
Transcriptional regulatory mechanisms shaping HIV proviral fateR01AI114362 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI D'ORSO, IVAN · 2015 to 2024
$4.6M
Novel small molecules to reactivate latent HIV and sensitize to anti-viral therapiesR33AI116222 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI D'ORSO, IVAN, MARTINEZ, ELISABETH D · 2016 to 2018
$1.5M
Preclinical Development of Ingenol and HDACi Toward HIV EradicationR33AI122377 · NIAID · UNIVERSITY OF UTAH · PI PLANELLES, VICENTE · 2018 to 2020
$1.1M
Transcriptional regulatory mechanisms shaping HIV proviral fateR37AI114362 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Ivan D'Orso · 2025 to 2026
$1.0M
CRISPR/Cas9 technology toward understanding HIV latency in primary cellsR21AI123035 · NIAID · UNIVERSITY OF UTAH · PI PLANELLES, VICENTE, SCHUBERT, HEIDI L · 2016 to 2017
$416k
NIAID NIH HHS R01 AI114362NIAID NIH HHS R21 AI123035NIAID NIH HHS R33 AI116222NIAID NIH HHS R33 AI122377NIAID NIH HHS R37 AI114362NIAID NIH HHS U01 AI111598NIGMS NIH HHS T32 GM007062
6 · The paper itself

Abstract

Transcriptional circuit architectures in several organisms have been evolutionarily selected to dictate precise given responses. Unlike these cellular systems, HIV is regulated through a complex circuit composed of two successive phases (host and viral), which create a positive feedback loop facilitating viral replication. However, it has long remained unclear whether both phases operate identically and to what extent the host phase influences the entire circuit. Here, we report that, although the host phase is regulated by a checkpoint whereby KAP1 mediates transcription activation, the virus evolved a minimalist system bypassing KAP1. Given the complex circuit's architecture, cell-to-cell KAP1 fluctuations impart heterogeneity in the host transcriptional responses, thus affecting the feedback loop. Mathematical modeling of a complete circuit reveals how these oscillations ultimately influence homogeneous reactivation potential of a latent virus. Thus, although HIV drives molecular innovation to fuel robust gene activation, it experiences transcriptional fragility, thereby influencing viral fate and cure efforts.

Indexed as

ProvirusesCells, CulturedGene Expression Regulation, ViralGene Regulatory NetworksGenome, ViralGenomic InstabilityHEK293 CellsHIV-1HIV InfectionsHumansJurkat CellsTranscription, GeneticVirus ActivationVirus LatencyVirus ReplicationHIVKAP1latencymathematical modelingprovirusP-TEFbreactivationstochastic modeltranscriptional regulationTRIM28

Identifiers

PMID30943398
PMCPMC6461408
OpenAlexW2906585256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.